Delivery Order SPE2DB22D1017-SPE2DB24FF2AN
- Not listed
- The Defense Logistics Agency (DLA) awarded a $111,675.29 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML. This delivery order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to supply pharmaceuticals and medical supplies in support of military treatment programs and facilities. The contract did not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $44,517.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply STELARA 90 MG/ML SYRINGEML pharmaceutical products. The delivery order was issued under an existing contract with the agency to provide pharmaceuticals, medical supplies, and distribution services to support military treatment programs and facilities. Amerisourcebergen Drug Corp has extensive experience as a prime...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide STELARA 90 MG/ML syringe medication. The $13,471.18 delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of December 29, 2023. This order is not associated with a set-aside program. AmerisourceBergen Drug Corp is an experienced federal contractor, having...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $47,645.06 contract is for the provision of STELARA 90 MG/ML syringes, with a completion date of January 3, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp's Corporate Office division has received numerous DLA contracts to supply...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply STELARA 90 MG/ML syringes. The contract has a potential value of $100,647.90 and a period of performance through February 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award, which does not have a set-aside designation. The company also holds an indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of STELARA 90 MG/ML SYRINGE ML pharmaceuticals. The $13,831.90 contract has a completion date of December 21, 2023 and was awarded on December 20, 2023. No set-aside designation was used for this award, which will be performed at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML pharmaceuticals. The $109,586.50 contract has an October 14, 2021 completion date and was awarded on October 13, 2021. Amerisourcebergen Drug Corp has a long history of providing pharmaceutical and medical supply products and distribution services to support DLA's programs, including...
- The Defense Logistics Agency awarded a $15,809.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. As the prime contractor, Amerisourcebergen will provide the pharmaceutical products to the DLA under a three-day period of performance from July 21 to July 24, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform the contract from its location in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply STELARA 90 MG/ML syringes. The $48,350.93 contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation mentioned. This delivery order is likely part of a larger indefinite delivery contract (IDC) Amerisourcebergen holds with...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of STELARA 90 MG/ML SYRINGES. The $7,504.40 contract has a completion date of February 27, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and is the sole recipient of this order, which is not associated with any set-aside designations. In addition to...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF2ANDelivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 mg/mL syringes. The $14,035.78 contract has a completion date of January 30, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a for-profit organization that serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense. This delivery order contract is one of several awards Amerisourcebergen Drug Corp has received from DLA to support military treatment programs and facilities with specialty, brand name, generic, and over-the-counter medications, as well as medical materials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 1/29/24 |